Skip to main content
. 2012 Oct 19;12:482. doi: 10.1186/1471-2407-12-482

Table 2.

Response to maintenance Bevacizumab (mBev) according to activity of Bevacizumab plus Paclitaxel (BT)

 
Response mBev
Activity BT
CR
PR
SD
PD
n n(%) n(%) n(%) n(%)
4 CR
4 (100)
 
 
 
18 PR
 
12 (66.7)
 
6 (33.3)
13 SD   1 (7.7) 10 (76.9) 2 (15.4)

mBev, maintenance Bevacizumab; CR, complete response; PR, partial response; SD, stable disease; PD, progression disease.